Global Blood Therapeutics (GBT) ROE US GAAP (year values)

2017 2018 2019 2020 2021   LTM ? CAGR 5 years ?
ROE, % ? -36.7% -30.4% -46.1% -59.5% -154.3%   -275.7%  
Changes by years, y/y, % +8pp +6pp -16pp -13pp -95pp     +28.4%

Global Blood Therapeutics. ROE, %

Global Blood Therapeutics. ROE, changes, pp

Global Blood Therapeutics (GBT) ROE US GAAP (quarter values)

2021Q2 2021Q3 2021Q4 2022Q1 2022Q2   LTM ?
ROE, % ? -84.3% -90.0% -156.3% -234.0% -275.7%   -275.7%
Changes by years, y/y, % -27pp -28pp -97pp -165pp -191pp    
Changes by quarters, q/q, % -16pp -6pp -66pp -78pp -42pp    

Global Blood Therapeutics. ROE, %

Global Blood Therapeutics. ROE, changes, pp

Global Blood Therapeutics. ROE, changes, pp